Effect of Bismuth Add-on to Dual Therapy for Helicobacter Pylori Eradication

Abroad (travel likely)RecruitingPHASE3

Conditions

HELICOBACTER PYLORI INFECTIONS

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

National Taiwan University Hospital, Taipei, Taiwan
Contact: Study coordinator (Mei-Jyh Chen, MD) · migichen@ntuh.gov.tw · 886-2-23123456 Ext. 63541

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Head-to-head Study of Tegoprazan 50 mg BID Plus Amoxicillin 1 g TID vs. Vonoprazan 20 mg BID Plus Amoxicillin 1 g TID for H. Pylori Eradication

Helicobacter Pylori Infection

Abroad (travel likely)RecruitingPHASE2, PHASE3

Hangzhou, China

A Study of the Safety of Vonoprazan Exposure in Pregnant Women and Their Offspring

Erosive Esophagitis · Heartburn · Symptomatic Non-erosive Gastroesophageal Reflux Disease

Abroad (travel likely)Recruiting

Wilmington, United States

High-dose Dual Therapy and Minocycline-cotaining Quadruple Therapy for Helicobacter Pylori Infection

Helicobacter Pylori Infection

Abroad (travel likely)RecruitingPHASE4

Hebi, China · Jiaozuo, China

Saccharomyces Boulardii Combined With Bismuth Quadruple Therapy for Helicobacter Pylori Rescue Treatment

Gastritis · Dyspepsia · Helicobacter Pylori Infection

Abroad (travel likely)RecruitingPHASE4

Xi'an, China